{
    "id": "0610",
    "question": "A 23-year-old woman, gravida 2, para 1, at 20 weeks of gestation comes to the physician for a routine prenatal exam. Her last pregnancy was unremarkable and she gave birth to a healthy rhesus (RhD) positive girl. Her past medical history is notable for a blood transfusion after a car accident with a complex femur fracture about 3 years ago. Her temperature is 37.2\u00b0C (99\u00b0F), pulse is 92/min, and blood pressure is 138/82 mm Hg. Examination shows that the uterus is at the umbilicus. Ultrasound examination reveals normal fetal heart rate, movement, and anatomy. Routine prenatal labs show the following:\nBlood type A Rh-\nLeukocyte count 11,000/mm3\nHemoglobin 12.5 g/dL\nPlatelet count 345,000/mm3\nSerum\nAnti-D antibody screen Negative\nRubella IgM Negative\nRubella IgG Negative\nVaricella IgM Negative\nVaricella IgG Positive\nSTD panel Negative\nUrine\nProtein Trace\nCulture No growth\nCervical cytology Normal\nWhich of the following is the best next step in management of this patient?\"",
    "options": {
        "A": "Repeat antibody screening at 28 weeks. Administer anti-D immunoglobulin at 28 weeks and after delivery if the newborn is Rh(D) positive.",
        "B": "Repeat antibody screening at 28 weeks and administer anti-D immunoglobulin at 28 weeks. No further management is needed.",
        "C": "No further screening is needed. Administer anti-D immunoglobulin shortly after delivery",
        "D": "No further management is needed\n\""
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine the best next step in management for this patient, we need to consider her previous blood transfusion history and the current antibody screening results. Given that she had a blood transfusion 3 years ago, there is a risk of developing antibodies against the RhD antigen. The current antibody screening results show that the anti-D antibody is negative, which indicates that she has not developed any antibodies against the RhD antigen. However, the fact that she received a blood transfusion in the past increases the risk of developing antibodies against the RhD antigen. The American College of Obstetricians and Gynecologists (ACOG) recommends that Rh-negative women who have received a blood transfusion should be tested for the presence of anti-D antibodies at 28 weeks of gestation and again shortly after delivery. Since the patient is currently at 20 weeks of gestation, repeating the antibody screening at 28 weeks would be appropriate. Additionally, administering anti-D immunoglobulin at 28 weeks and after delivery if the newborn is Rh(D) positive would be necessary to prevent the formation of antibodies against the RhD antigen. The patient's other laboratory results, including the rubella and varicella screening, do not provide any relevant information for this specific situation. Therefore, the best next step in management for this patient is to repeat the antibody screening at 28 weeks and administer anti-D immunoglobulin at 28 weeks and after delivery if the newborn is Rh(D) positive.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 8.703431367874146
}